Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-10-15
2009-10-06
Anderson, Rebecca L (Department: 1626)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
C544S127000
Reexamination Certificate
active
07598243
ABSTRACT:
The present invention is directed to compounds of the formula I:Wherein R1, R2, R3, R4, R5, R6, R7, R8, R9, X, n and the broken lines are as defined herein which are useful as modulators of chemokine receptor activity. In particular, these compounds are useful as modulators of the chemokine receptor CCR-2.
REFERENCES:
patent: WO 02/13824 (2002-02-01), None
patent: WO 03/093231 (2003-11-01), None
patent: WO 2004/094371 (2004-11-01), None
patent: WO 2004/110376 (2004-12-01), None
Butora Gabor
Goble Stephen D.
Moyes Christopher R.
Pasternak Alexander
Yang Lihu
Anderson Rebecca L
Daniel Mark R.
McGinnis James L.
Merck & Co. , Inc.
LandOfFree
Heterocyclic cyclopentyl tetrahydroisoquinoline and... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Heterocyclic cyclopentyl tetrahydroisoquinoline and..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Heterocyclic cyclopentyl tetrahydroisoquinoline and... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4113620